Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016

Vladimir Zah,1 Rowe B Brookﬁeld,2 Martina Imro,1 Simona Tatovic,1 Jovana Pelivanovic,1 Djurdja Vukicevic1 1Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc, Mississauga, Ontario, Canada; 2Field Medical Affairs, Depomed, Inc, Newark, CA, USACorrespondence: Vladimir ZahHeal...

Full description

Bibliographic Details
Main Authors:	Zah V, Brookﬁeld RB, Imro M, Tatovic S, Pelivanovic J, Vukicevic D
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-11-01
Series:	Journal of Pain Research
Subjects:	long-acting opioids real-world evidence administrative database cost analysis subgroup analysis.
Online Access:	https://www.dovepress.com/healthcare-costs-and-resource-utilization-in-chronic-pain-patients-tre-peer-reviewed-article-JPR

Similar Items

Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
by: Gertrud Haeseler, et al.
Published: (2017-07-01)

New opioid analgesic tapentadol in the treatment of neuropathic pain in oncology
by: R. R. Sarmanaeva, et al.
Published: (2019-06-01)

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
by: Nosek K, et al.
Published: (2017-08-01)

Tapentadol extended release for the management of chronic neck pain
by: Billeci D, et al.
Published: (2017-03-01)

Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain
by: Bram C. Agema, et al.
Published: (2021-06-01)

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
by: Zah V, et al.
Published: (2020-11-01)

Tapentadol and Oxycodone/Naloxone Prescribing Patterns in Primary Health Care in Catalonia, Spain: A Cross-Sectional Study
by: Viñas-Bastart M, et al.
Published: (2021-10-01)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
by: Jordi Barrachina, et al.
Published: (2022-10-01)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
by: Jordi Barrachina, et al.
Published: (2022-06-01)

Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients
by: Muse D, et al.
Published: (2019-05-01)

Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study
by: Tiziana D’Amato, et al.
Published: (2019-07-01)

Tapentadol hydrochloride: A novel analgesic
by: Dewan Roshan Singh, et al.
Published: (2013-01-01)

Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes
by: Julien Tanniou, et al.
Published: (2016-02-01)

Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
by: Guerriero F, et al.
Published: (2014-12-01)

Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
by: Ueberall MA, et al.
Published: (2016-02-01)

A Randomized Controlled Trial on the Effect of Tapentadol and Morphine on Conditioned Pain Modulation in Healthy Volunteers.
by: Chris Martini, et al.
Published: (2015-01-01)

Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations
by: Kibbe AH, et al.
Published: (2018-04-01)

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18
by: Finkel JC, et al.
Published: (2019-06-01)

Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination—the SPIRAL study
by: Cornelis Jan van Dam, et al.
Published: (2023-01-01)

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product
by: Pergolizzi, J, et al.
Published: (2018-02-01)

Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe
by: Montserrat Casamayor, et al.
Published: (2018-04-01)

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
by: Saito Y, et al.
Published: (2018-12-01)

Levorphanol in the Perioperative Setting: Decreasing Opioid Requirements While Improving Pain Management
by: Page CR, et al.
Published: (2020-10-01)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
by: Jan C. Otto, et al.
Published: (2019-09-01)

Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation.
by: Junxiang Zhou, et al.
Published: (2020-01-01)

Repurposed oral tapentadol as an intravenous drug of abuse in opioid dependence
by: Arshiya Fathima, et al.
Published: (2022-01-01)

Efetividade do tapentadol na dor oncológica - uma revisão sistemática
by: Ana Rita Aguadeiro Santos Baptista
Published: (2019-06-01)

Oxycodone for cancer-related pain in adults (Russian Translation of Cochrane Plain Language Summary (PLS))
by: Regina F. Bayazitova
Published: (2023-02-01)

Meperidine (pethidine) versus morphine in acute pain management of opioid-dependent patients
by: Solhi H, et al.
Published: (2016-08-01)

Oxycodone regulates incision-induced activation of neurotrophic factors and receptors in an acute post-surgery pain rat model
by: Liu BW, et al.
Published: (2018-10-01)

Oxycodone, an opioid like the others?
by: Nicolas Marie, et al.
Published: (2023-12-01)

Efficacy And Safety Of Controlled-Release Oxycodone For The Management Of Moderate-To-Severe Chronic Non-Cancer Pain In Japanese Patients: Results From An Open-Label Study
by: Kawamata M, et al.
Published: (2019-12-01)

Cost-Effectiveness and Cost–Utility Analyses in Thailand of Continuous Intrathecal Morphine Infusion Compared with Conventional Therapy in Cancer Pain: A 10-year Multicenter Retrospective Study
by: Arpawan Thepsuwan, et al.
Published: (2023-12-01)

The association between subgroups of MRI findings identified with latent class analysis and low back pain in 40-year-old Danes
by: Rikke K. Jensen, et al.
Published: (2018-02-01)

Estudo de biomarcadores de toxicidade decorrente da exposição de opioides: o tapentadol
by: Margarida Ferrão, et al.
Published: (2022-04-01)

Tapentadol: an effective option for the treatment of back pain
by: Coluzzi F, et al.
Published: (2019-05-01)

Improved Morphine-Loaded Hydrogels for Wound-Related Pain Relief
by: Dinis Mateus, et al.
Published: (2019-02-01)

Epidural Oxycodone for Acute Pain
by: Panu Piirainen, et al.
Published: (2022-05-01)

Stratified split sampling of electronic health records
by: Tianyao Huo, et al.
Published: (2023-05-01)

Multiple effectiveness aspects of tapentadol for moderate–severe cancer-pain treatment: an observational prospective study
by: Cascella M, et al.
Published: (2018-12-01)